GB750373A
(en)
|
1953-01-15 |
1956-06-13 |
Pfizer & Co C |
Improvements in or relating to injectable suspension of penicillin salts
|
DK128416B
(da)
|
1964-08-13 |
1974-04-29 |
Ciba Geigy Ag |
Analogifremgangsmåde til fremstilling af adrenocorticotropt aktive nonadecapeptidamider eller syreadditionssalte eller kompleksforbindelser deraf.
|
BE757195A
(fr)
|
1969-10-07 |
1971-03-16 |
Century Disposable Devices |
Seringue servant a injecter un melange fraichement prepare de poudre etde liquide
|
JPS5270014A
(en)
|
1975-12-05 |
1977-06-10 |
Senju Pharma Co |
Stabilization of pyrido*3*22a*phenoxadine compounds
|
US4171698A
(en)
|
1977-08-15 |
1979-10-23 |
Abbott Laboratories |
Prefilled two-compartment syringe
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
DE3650349T2
(de)
|
1985-03-15 |
1995-12-14 |
Antivirals Inc |
Immunotestmittel für polynukleotid und verfahren.
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
AU4128089A
(en)
|
1988-09-15 |
1990-03-22 |
Rorer International (Overseas) Inc. |
Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
|
US5001000A
(en)
|
1988-09-26 |
1991-03-19 |
E. I. Du Pont De Nemours And Company |
Process for forming a composite structure of thermoplastic polymer and sheet molding compound
|
US5114703A
(en)
*
|
1989-05-30 |
1992-05-19 |
Alliance Pharmaceutical Corp. |
Percutaneous lymphography using particulate fluorocarbon emulsions
|
US5730978A
(en)
|
1989-09-01 |
1998-03-24 |
Fred Hutchinson Cancer Research Center |
Inhibition of lymphocyte adherence with α4β1-specific antibodies
|
US6033665A
(en)
|
1989-09-27 |
2000-03-07 |
Elan Pharmaceuticals, Inc. |
Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
|
JPH03190823A
(ja)
|
1989-12-21 |
1991-08-20 |
Snow Brand Milk Prod Co Ltd |
エリスロポエチン皮下又は筋肉投与剤
|
US5698195A
(en)
|
1991-03-18 |
1997-12-16 |
New York University Medical Center |
Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
LU91067I2
(fr)
|
1991-06-14 |
2004-04-02 |
Genentech Inc |
Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
NZ261259A
(en)
|
1993-01-12 |
1996-12-20 |
Biogen Inc |
Humanised recombinant anti-vla4 antibody and diagnostic compositions and medicaments
|
US5334162A
(en)
|
1993-03-15 |
1994-08-02 |
Eli Lilly And Company |
Cartridge assembly for a lyophilized compound forming a disposable portion of an injector pen and method for same
|
US5744155A
(en)
*
|
1993-08-13 |
1998-04-28 |
Friedman; Doron |
Bioadhesive emulsion preparations for enhanced drug delivery
|
US5527675A
(en)
|
1993-08-20 |
1996-06-18 |
Millipore Corporation |
Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
|
DE4331012A1
(de)
|
1993-09-13 |
1995-03-16 |
Bayer Ag |
Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
GB9418092D0
(en)
|
1994-09-08 |
1994-10-26 |
Red Cross Found Cent Lab Blood |
Organic compounds
|
JP3524974B2
(ja)
|
1994-12-26 |
2004-05-10 |
ブラッコ インターナショナル ビーヴィ |
プレフィルドシリンジおよびその包装体
|
US5569193A
(en)
|
1995-03-22 |
1996-10-29 |
Abbott Laboratories |
Syringe system accommodating separately storable prefilled containers for two constituents
|
US5779668A
(en)
|
1995-03-29 |
1998-07-14 |
Abbott Laboratories |
Syringe barrel for lyophilization, reconstitution and administration
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
DE19617369A1
(de)
|
1996-04-30 |
1997-11-06 |
Immuno Ag |
Lagerstabile Fibrinogen-Präparate
|
US6184037B1
(en)
*
|
1996-05-17 |
2001-02-06 |
Genemedicine, Inc. |
Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
US5819998A
(en)
|
1996-09-30 |
1998-10-13 |
Everything Kids |
Knapsack with simulated basketball court
|
IN184589B
(es)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
US6065645A
(en)
|
1997-04-01 |
2000-05-23 |
Discus Dental Impressions, Inc. |
Double-barreled syringe with detachable locking mixing tip
|
US5819988A
(en)
|
1997-04-01 |
1998-10-13 |
Sawhney; Ravi K. |
Double-barreled syringe with detachable locking mixing tip
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US5786571A
(en)
|
1997-05-09 |
1998-07-28 |
Lexmark International, Inc. |
Wrapped temperature sensing assembly
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
US6808706B1
(en)
|
1997-10-15 |
2004-10-26 |
Asaki Kasei Pharma Corporation |
Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
|
DE69837399T2
(de)
|
1997-10-22 |
2007-12-20 |
Chugai Seiyaku K.K. |
Verfahren zum screening von tgf-beta inhibierenden substanzen
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
FR2794649B1
(fr)
*
|
1999-06-11 |
2003-04-11 |
Solutions |
Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
|
AUPQ132599A0
(en)
*
|
1999-07-01 |
1999-07-22 |
Commonwealth Scientific And Industrial Research Organisation |
Nasogastric enteral formulations
|
US7030097B1
(en)
|
1999-07-14 |
2006-04-18 |
Cornell Research Foundation, Inc. |
Controlled nucleic acid delivery systems
|
EP1072323B1
(de)
|
1999-07-29 |
2003-09-10 |
Wilhelm A. Keller |
Kartuschen-Austraggerät mit Antrieb für dynamischen Mischer
|
HU0800692D0
(en)
|
1999-10-04 |
2009-01-28 |
Novartis Vaccines & Diagnostic |
Stabilized liquid polypeptide-containing pharmaceutical compositions
|
US6394314B1
(en)
|
1999-10-12 |
2002-05-28 |
Discus Dental Impressions, Inc. |
Double-barreled syringe with detachable locking mixing tip
|
US6443612B1
(en)
|
1999-12-02 |
2002-09-03 |
Wilhelm A. Keller |
Dynamic mixer
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
DE60139944D1
(de)
|
2000-10-12 |
2009-10-29 |
Genentech Inc |
Niederviskose konzentrierte proteinformulierungen
|
EP1339442A4
(en)
|
2000-11-30 |
2006-12-27 |
Biovalve Technologies Inc |
INJECTION SYSTEMS
|
DK2813582T3
(en)
|
2000-12-01 |
2017-07-31 |
Max-Planck-Gesellschaft Zur Förderung Der Wss E V |
Small RNA molecules that mediate RNA interference
|
JP2005501814A
(ja)
|
2001-05-16 |
2005-01-20 |
バイオマリン ファーマシューティカル インコーポレイテッド |
ビブリオリシンまたはその改変体を用いるプリオンの破壊
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
JP4317010B2
(ja)
|
2001-07-25 |
2009-08-19 |
ピーディーエル バイオファーマ,インコーポレイティド |
IgG抗体の安定な凍結乾燥医薬製剤
|
BR0211579A
(pt)
|
2001-08-02 |
2004-07-13 |
3M Innovative Properties Co |
Vidro-cerâmica, contas, pluralidade de partìculas abrasivas, artigo abrasivo, e, métodos para abradar uma superfìcie, para fabricar vidro-cerâmica, para fabricar um artigo de vidro-cerâmica e para fabricar partìculas abrasivas
|
JP4167820B2
(ja)
|
2001-10-19 |
2008-10-22 |
アルインコ株式会社 |
デッキプレート走行台車
|
GB0212405D0
(en)
|
2002-05-29 |
2002-07-10 |
Insignion Holdings Ltd |
Composition and its therapeutic use
|
US9415102B2
(en)
|
2002-09-06 |
2016-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration formulations of anti-C5 antibodies
|
US20040191243A1
(en)
|
2002-12-13 |
2004-09-30 |
Bei Chen |
System and method for stabilizing antibodies with histidine
|
BRPI0408116B1
(pt)
|
2003-03-05 |
2022-09-20 |
Halozyme, Inc |
Polipeptídeos de hialuronidase solúveis conjugados a polímero, composições farmacêuticas compreendendo polipeptídeos ph20 solúveis, seus usos e processo de preparação, e ácidos nucléicos que codificam polipeptídeos de hialuronidase solúveis
|
CA2520775A1
(en)
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
US20050158303A1
(en)
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
PT1610820E
(pt)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
Formulações de elevada concentração de anticorpos e proteínas
|
US7341843B2
(en)
|
2003-04-11 |
2008-03-11 |
Allergan, Inc. |
Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
|
JP2006523461A
(ja)
|
2003-04-15 |
2006-10-19 |
イスタ・ファーマスーティカルズ・インコーポレイテッド |
羊ヒアルロニダーゼを単離し精製する方法
|
US20040247672A1
(en)
|
2003-05-16 |
2004-12-09 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
JP2007516181A
(ja)
*
|
2003-06-23 |
2007-06-21 |
アヴェンティス パストゥール インコーポレイテッド |
髄膜炎菌血清群aおよびcに対する免疫方法
|
CN1206344C
(zh)
|
2003-07-28 |
2005-06-15 |
中国海洋大学 |
一种用细菌生产岩藻聚糖硫酸酯酶的方法
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
AU2004317954A1
(en)
|
2003-09-17 |
2005-10-13 |
Chiasma, Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
GB0403938D0
(en)
*
|
2004-02-21 |
2004-03-24 |
West Pharm Serv Drug Res Ltd |
Chitosan containing solution
|
EP1669414B1
(en)
|
2004-11-25 |
2010-05-26 |
Chr. Hansen A/S |
Method for the preparation of a carminic acid lake
|
US20060142234A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060141040A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
CN103271083B
(zh)
|
2005-10-07 |
2017-08-11 |
阿拉巴马大学 |
多功能离子液体组合物
|
CN100416002C
(zh)
|
2005-10-26 |
2008-09-03 |
曲新华 |
污水再生利用装置
|
US9309316B2
(en)
|
2005-12-20 |
2016-04-12 |
Bristol-Myers Squibb Company |
Stable subcutaneous protein formulations and uses thereof
|
EP1962886B2
(en)
|
2005-12-20 |
2022-02-23 |
Bristol-Myers Squibb Company |
Stable protein formulations
|
AU2006330858A1
(en)
|
2005-12-21 |
2007-07-05 |
Wyeth |
Protein formulations with reduced viscosity and uses thereof
|
EP1977763A4
(en)
|
2005-12-28 |
2010-06-02 |
Chugai Pharmaceutical Co Ltd |
STABILIZER PREPARATION CONTAINING ANTIBODIES
|
JP2009525986A
(ja)
|
2006-02-03 |
2009-07-16 |
メディミューン,エルエルシー |
タンパク質製剤
|
DE102006005094A1
(de)
|
2006-02-04 |
2007-08-09 |
Degussa Gmbh |
Titandioxid und Polycarboxylatether enthaltende Dispersion
|
ITMI20061030A1
(it)
*
|
2006-05-26 |
2007-11-27 |
Altergon Sa |
Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
|
CU23526B6
(es)
|
2006-10-03 |
2010-05-19 |
Ct Ingenieria Genetica Biotech |
Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética
|
US20090022727A1
(en)
|
2007-01-26 |
2009-01-22 |
Alza Corp. |
Injectable, nonaqueous suspension with high concentration of therapeutic agent
|
CN101765423B
(zh)
|
2007-05-31 |
2014-08-06 |
安特里奥公司 |
核酸纳米粒子和其用途
|
WO2009015367A2
(en)
|
2007-07-25 |
2009-01-29 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Stabilizing proteins using ionic liquids
|
JP2010536786A
(ja)
|
2007-08-17 |
2010-12-02 |
アムジエン・インコーポレーテツド |
ポリカチオンを用いた抗体およびfc融合分子の製剤
|
EP2205280B1
(en)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmaceutical formulations
|
EA019258B1
(ru)
*
|
2007-10-16 |
2014-02-28 |
Фармасайкликс, Инк. |
КОМПОЗИЦИИ, СОДЕРЖАЩИЕ МОДУЛЯТОРЫ ФАКТОРА КОАГУЛЯЦИИ VIIa, И ИХ ПРИМЕНЕНИЕ
|
US8796206B2
(en)
|
2007-11-15 |
2014-08-05 |
Amgen Inc. |
Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
|
WO2009086062A1
(en)
|
2007-12-21 |
2009-07-09 |
Lyotropic Therapeutics, Inc. |
Stabilized formulations of peptides and proteins
|
PE20091174A1
(es)
|
2007-12-27 |
2009-08-03 |
Chugai Pharmaceutical Co Ltd |
Formulacion liquida con contenido de alta concentracion de anticuerpo
|
WO2009120684A1
(en)
|
2008-03-25 |
2009-10-01 |
Medimmune, Llc |
Antibody formulation
|
WO2009137471A2
(en)
|
2008-05-05 |
2009-11-12 |
University Of Miami |
Azo dye related small molecule modulators of protein-protein interactions
|
EP2123307A1
(en)
|
2008-05-20 |
2009-11-25 |
Hexal Ag |
Method for reducing leachables and extractables in syringes
|
WO2010056657A2
(en)
*
|
2008-11-16 |
2010-05-20 |
Board Of Regents, The Univesity Of Texas System |
Low viscosity highly concentrated suspensions
|
TWI342781B
(en)
|
2008-12-01 |
2011-06-01 |
Univ China Medical |
Blood sugar-modulating polypeptides
|
SG174258A1
(en)
|
2009-03-06 |
2011-10-28 |
Genentech Inc |
Antibody formulation
|
WO2010132047A1
(en)
|
2009-05-14 |
2010-11-18 |
Rensselaer Polytechnic Institute |
Guanosine/gmp gels and uses thereof
|
KR101882408B1
(ko)
|
2009-05-20 |
2018-07-27 |
세키스이 메디칼 가부시키가이샤 |
혈액응고시간 연장제
|
EP2475376B1
(en)
|
2009-06-17 |
2016-03-30 |
BioMarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
WO2011017330A1
(en)
|
2009-08-04 |
2011-02-10 |
Genentech Inc |
Concentrated polypeptide formulations with reduced viscosity
|
JP5734985B2
(ja)
|
2009-09-17 |
2015-06-17 |
バクスター・ヘルスケヤー・ソシエテ・アノニムBaxter Healthcare SA |
ヒアルロニダーゼおよび免疫グロブリンの安定な共製剤およびそれらの使用方法
|
US8895242B2
(en)
|
2009-10-20 |
2014-11-25 |
The Regents Of The University Of California |
Single molecule nucleic acid nanoparticles
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
EP3721904B1
(en)
|
2009-11-20 |
2021-10-13 |
Biocon Limited |
Formulations of t1h antibody
|
US9289381B2
(en)
|
2009-12-03 |
2016-03-22 |
The University Of North Carolina At Charlotte |
Stabilization and storage of biological pharmaceutical compositions
|
PL2816112T3
(pl)
|
2009-12-10 |
2019-03-29 |
Regents Of The University Of Minnesota |
Modyfikacja DNA za pośrednictwem efektorów TAL
|
JP5746214B2
(ja)
|
2010-01-08 |
2015-07-08 |
シャネル パフュームズ ビューテ |
皮膚に潤いを与えるための、ヤブツバキアルバプレナ(CamelliaJaponicaAlbaPlena)の花の少なくとも1つの抽出物の使用
|
PL2531218T3
(pl)
|
2010-02-04 |
2019-05-31 |
Csl Behring Ag |
Preparat immunoglobuliny
|
JP2013520476A
(ja)
|
2010-02-26 |
2013-06-06 |
ノヴォ ノルディスク アー/エス |
安定な抗体含有組成物
|
EP2542221A4
(en)
|
2010-03-01 |
2013-10-23 |
Cytodyn Inc |
CONCENTRATED PROTEIN FORMULATIONS AND USES THEREOF
|
US20130171128A1
(en)
|
2010-03-02 |
2013-07-04 |
Amgen Inc. |
Reducing viscosity of pharmaceutical formulations
|
US9072668B2
(en)
|
2010-03-09 |
2015-07-07 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
|
BR112012023895A2
(pt)
|
2010-03-17 |
2016-11-29 |
Abbott Res Bv |
composições de anti-fator de crescimento do nervo (ngf)
|
WO2011121560A2
(en)
|
2010-03-31 |
2011-10-06 |
Universite De Geneve |
Stabilized antibody preparations and uses thereof
|
CN101851267A
(zh)
|
2010-04-22 |
2010-10-06 |
江南大学 |
一种抗体保护剂及其应用
|
BR112012027828A2
(pt)
|
2010-05-03 |
2016-08-09 |
Genentech Inc |
composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína
|
GB201012179D0
(en)
|
2010-07-20 |
2010-09-01 |
Future Injection Technologies |
Injection device
|
US8936827B2
(en)
*
|
2011-02-25 |
2015-01-20 |
Abbott Cardiovascular Systems Inc. |
Methods of loading a hollow stent with a drug or drug formulation
|
EP3058952A1
(en)
|
2011-04-07 |
2016-08-24 |
Glaxosmithkline LLC |
Formulations with reduced viscosity
|
CA2832560A1
(en)
|
2011-04-07 |
2012-10-18 |
Glaxosmithkline Llc |
Formulations with reduced viscosity
|
JP3181663U
(ja)
*
|
2011-05-12 |
2013-02-21 |
メドラッド、インク. |
流体送達システムで使用する注射器
|
RU2485133C2
(ru)
|
2011-05-30 |
2013-06-20 |
Закрытое Акционерное Общество "Фарм-Синтез" |
Белково-полипептидный комплекс, обладающий тканеспецифическим регенеративно-репаративным и омолаживающим действием на кожную ткань, способ его получения и фармацевтическая композиция на его основе
|
WO2013063258A1
(en)
|
2011-10-25 |
2013-05-02 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
CN104023748B
(zh)
|
2011-10-28 |
2018-03-02 |
诚信生物公司 |
含有氨基酸的蛋白质制剂
|
AR089434A1
(es)
|
2011-12-23 |
2014-08-20 |
Genentech Inc |
Procedimiento para preparar formulaciones con alta concentracion de proteinas
|
AU2013211824B2
(en)
|
2012-01-27 |
2017-06-01 |
Gliknik Inc. |
Fusion proteins comprising IgG2 hinge domains
|
US10160808B2
(en)
|
2012-02-16 |
2018-12-25 |
Santarus, Inc. |
Anti-VLA1 (CD49A) antibody pharmaceutical compositions
|
WO2013173789A2
(en)
*
|
2012-05-17 |
2013-11-21 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide compositions
|
US9574193B2
(en)
*
|
2012-05-17 |
2017-02-21 |
Ionis Pharmaceuticals, Inc. |
Methods and compositions for modulating apolipoprotein (a) expression
|
EP2849723B1
(en)
|
2012-05-18 |
2018-05-02 |
Genentech, Inc. |
High-concentration monoclonal antibody formulations
|
RS64622B1
(sr)
|
2012-05-25 |
2023-10-31 |
Univ California |
Metode i sastavi za modifikaciju ciljane dnk upravljenu pomoću rnk i za modulaciju transkripcije upravljanu rnk
|
CN104220047B
(zh)
|
2012-05-25 |
2019-11-15 |
诺华股份有限公司 |
含有生物治疗剂和胍或胍衍生物的水性药物组合物以及包含所述组合物的注射剂
|
JP6157611B2
(ja)
|
2012-06-21 |
2017-07-05 |
ユセベ ファルマ ソシエテ アノニム |
医薬製剤
|
ES2757623T3
(es)
|
2012-07-25 |
2020-04-29 |
Broad Inst Inc |
Proteínas de unión a ADN inducibles y herramientas de perturbación genómica y aplicaciones de las mismas
|
CN109705218B
(zh)
|
2012-08-09 |
2022-07-19 |
罗切格利卡特公司 |
Asgpr抗体及其用途
|
FR2994390B1
(fr)
|
2012-08-10 |
2014-08-15 |
Adocia |
Procede d'abaissement de la viscosite de solutions de proteines a concentration elevee
|
US9592297B2
(en)
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
FR2995214B1
(fr)
|
2012-09-10 |
2014-11-21 |
Adocia |
Solution a viscosite reduite de proteine a concentration elevee
|
WO2014160083A1
(en)
*
|
2013-03-13 |
2014-10-02 |
Applied Cardiovascular Solutions, Llc. |
Methods, compositions, and devices for the occlusion of cavities and passageways
|
US9669242B2
(en)
|
2013-07-01 |
2017-06-06 |
L'oreal |
Compositions containing at least two phenolic compounds, a lipid-soluble antioxidant and at least one hydrotrope for cosmetic use
|
EP3808338A1
(en)
|
2013-09-11 |
2021-04-21 |
Eagle Biologics, Inc. |
Liquid protein formulations containing ionic liquids
|
US20160074515A1
(en)
|
2014-06-20 |
2016-03-17 |
Reform Biologics, Llc |
Viscosity-reducing excipient compounds for protein formulations
|